R. Tyler Hillman, MD, PhD, is assistant professor in the Department of Gynecologic Oncology and Reproductive Medicine of the Division of Surgery at The University of Texas MD Anderson Cancer.
Dr Hillman on Identifying New Therapy Candidates in Adult-Type Granulosa Cell Tumor
R. Tyler Hillman, MD, PhD, discusses ways of identifying new drug therapy candidates in patients with adult-type granulosa cell tumor of the ovary.
Read More
Durvalumab Plus Chemo May be Promising Neoadjuvant Option in UTUC
Dr Patel on the Potential for Adjuvant Immunotherapy in CSCC
Observation Is a Reasonable Alternative to Adjuvant PD-1 Blockade in Stage IIB/IIIC Melanoma
Dr Oluwole on CRS and Neurotoxicity Beyond 2 Weeks After Axi-Cel Infusion in R/R LBCL
Ibrutinib/Venetoclax/Obinutuzumab Controls Disease at 5 Years in Newly Diagnosed MCL
Updated Clinical Trial Data Reflect Efforts to Optimize IO Combos in Non-ccRCC and MIBC, Fine-Tune ADT-Based Regimens in Prostate Cancer
Dr Lheureux on Advancements in Targeted Treatment Delivery for Ovarian Cancer
Data Continue to Reshape Treatment Considerations Across Advanced GI Malignancies